Cargando…
Management of poor-prognosis testicular germ cell tumors
Currently, the outcome of patients with intermediate-and poor-risk germ cell tumors at diagnosis is optimized by the use of risk-appropriate chemotherapy and post-chemotherapy surgical resection of residual masses. Currently, there is no role for high-dose chemotherapy in the first-line setting. Pat...
Autores principales: | Khurana, Kiranpreet, Gilligan, Timothy D., Stephenson, Andrew J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878420/ https://www.ncbi.nlm.nih.gov/pubmed/20535296 http://dx.doi.org/10.4103/0970-1591.61228 |
Ejemplares similares
-
Intratubular germ cell neoplasms of the testis and bilateral testicular tumors: Clinical significance and management options
por: Risk, Michael C., et al.
Publicado: (2010) -
Management options for stage 1 nonseminomatous germ cell tumors of the testis
por: Beck, Stephen D. W.
Publicado: (2010) -
Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis
por: Fitzgerald, John P., et al.
Publicado: (2010) -
Management of good-risk metastatic nonseminomatous germ cell tumors of the testis: Current concepts and controversies
por: Jayram, Gautam, et al.
Publicado: (2010) -
MGMT and CALCA promoter methylation are associated with poor prognosis in testicular germ cell tumor patients
por: Martinelli, Camila Maria da Silva, et al.
Publicado: (2016)